XML 54 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
Years Ended December 31,
202420232022
Subscriber related$324 $211 $144 
Sales and marketing17,341 22,886 22,198 
Technology and development12,208 12,024 9,998 
General and administrative12,637 16,094 20,114 
$42,510 $51,215 $52,454 
Schedule of of Stock Option Activity
A summary of stock option activity for the year ended December 31, 2024, is as follows (in thousands, except share and per share amounts):
Number of Shares Weighted Average Exercise PriceTotal Intrinsic ValueWeighted Average Remaining Contractual Life
 (in years)
Outstanding as of December 31, 2023
10,475,607 $6.31 $6,534 5.3
Exercised(4,042)$0.87   
Forfeited or expired(275,333)$12.99   
Outstanding as of December 31, 2024
10,196,232 $6.13 $1,036 4.4
    
Options vested and exercisable as of December 31, 2024
9,610,252 $6.39 $1,036 4.3
A summary of activity under the Plan for market and service-based stock options for the year ended December 31, 2024 is as follows (in thousands, except share and per share amounts):
Number of SharesWeighted Average Exercise PriceTotal Intrinsic ValueWeighted Average Remaining Contractual Life
(in years)
Outstanding as of December 31, 2023
4,453,297 $12.75 $— 3.7
Outstanding as of December 31, 2024
4,453,297 $12.75 $— 2.7
    
Options vested and exercisable as of December 31, 2024
3,994,964 $11.96 $— 2.6
Schedule of Determining the Fair Value of Stock Options Granted
The following was used in determining the fair value of stock options granted:
December 31,
2023
Dividend yield— %
Expected price volatility49.8 %
Risk free interest rate3.9 %
Expected term (years)6.0
Schedule of Nonvested Restricted Stock Units Activity
A summary of the Company’s time-based restricted stock unit activity during the year ended December 31, 2024 is as follows:
Number of Shares Weighted Average Grant-Date Fair Value
Unvested at December 31, 2023
20,313,775 $3.85 
Granted15,812,986 $1.55 
Vested(7,095,430)$3.65 
Forfeited(2,321,974)$4.64 
Unvested at December 31, 2024
26,709,357 $2.47 
A summary of the Company’s performance-based restricted stock unit activity during the year ended December 31, 2024 is as follows:
Number of SharesWeighted Average Grant-Date Fair Value
Unvested at December 31, 2023
2,035,834 $7.75 
Granted1,185,819 $1.55 
Forfeited(189,825)$3.26 
Unvested at December 31, 2024
3,031,828 $5.61 
Schedule of Outstanding Warrants
A summary of the Company’s outstanding warrants as of December 31, 2024, are presented below (in thousands, except share and per share amounts):
Number of Warrants Weighted Average Exercise PriceTotal Intrinsic ValueWeighted Average Remaining Contractual Life
(in years)
Outstanding as of December 31, 2023
166,670 $17.40 $— 8.6
Outstanding as of December 31, 2024
166,670 $17.40 $— 7.6